COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics.

MAPK SARS-CoV-2 vitamin D

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
20 May 2023
Historique:
received: 18 04 2023
revised: 17 05 2023
accepted: 17 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

An uncontrolled inflammatory response during SARS-CoV-2 infection has been highlighted in several studies. This seems to be due to pro-inflammatory cytokines whose production could be regulated by vitamin D, ROS production or mitogen-activated protein kinase (MAPK). Several genetic studies are present in the literature concerning genetic influences on COVID-19 characteristics, but there are few data on oxidative stress, vitamin D, MAPK and inflammation-related factors, considering gender and age. Therefore, the aim of this study was to evaluate the role of single nucleotide polymorphisms in these pathways, clarifying their impact in affecting COVID-19-related clinical features. Genetic polymorphisms were evaluated through real-time PCR. We prospectively enrolled 160 individuals: 139 patients were positive for SARS-CoV-2 detection. We detected different genetic variants able to affect the symptoms and oxygenation. Furthermore, two sub-analyses were performed considering gender and age, showing a different impact of polymorphisms according to these characteristics. This is the first study highlighting a possible contribution of genetic variants of these pathways in affecting COVID-19 clinical features. This may be relevant in order to clarify the COVID-19 etiopathogenesis and to understand the possible genetic contribution for further SARS infections.

Identifiants

pubmed: 37237997
pii: antiox12051133
doi: 10.3390/antiox12051133
pmc: PMC10215473
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : University of Turin
ID : CUSJ_RILO_20_01
Organisme : University of Turin
ID : CALA_ RILO_20_01

Références

J Pediatr (Rio J). 2021 Jul-Aug;97(4):378-386
pubmed: 33058776
Chonnam Med J. 2022 Jan;58(1):1-5
pubmed: 35169552
J Steroid Biochem Mol Biol. 2020 Sep;202:105719
pubmed: 32535032
Free Radic Biol Med. 2013 Oct;63:222-34
pubmed: 23665396
Am J Physiol Endocrinol Metab. 2021 Aug 1;321(2):E246-E251
pubmed: 34181461
Sci Rep. 2021 Nov 9;11(1):21968
pubmed: 34753980
Am J Lifestyle Med. 2022 Nov 29;17(2):202-205
pubmed: 36883130
Cell Biochem Biophys. 2020 Jun;78(2):165-180
pubmed: 32441029
Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28
pubmed: 15951480
Exp Mol Med. 2018 Apr 16;50(4):1-14
pubmed: 29657326
Commun Biol. 2021 Apr 12;4(1):475
pubmed: 33846513
Adv Exp Med Biol. 2012;728:84-91
pubmed: 22396163
Sci Rep. 2015 Oct 08;5:14875
pubmed: 26445902
Br J Clin Pharmacol. 2013 Jun;75(6):1497-505
pubmed: 23116553
Trends Immunol. 2021 Jan;42(1):3-5
pubmed: 33214057
Exp Eye Res. 2007 Oct;85(4):462-72
pubmed: 17765224
PLoS One. 2022 May 27;17(5):e0269005
pubmed: 35622838
Nutrients. 2022 Nov 11;14(22):
pubmed: 36432468
Nutrients. 2020 Nov 14;12(11):
pubmed: 33202670
Emerg Microbes Infect. 2020 Dec;9(1):1123-1130
pubmed: 32475230
Breast Cancer Res Treat. 2003 Jul;80(1):49-62
pubmed: 12889598
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):280-91
pubmed: 20056649
Gene. 2022 Aug 5;834:146647
pubmed: 35680023
Arch Endocrinol Metab. 2023 Mar 10;67(2):276-288
pubmed: 36913680
FASEB J. 2022 Aug;36(8):e22451
pubmed: 35838947
Trends Immunol. 2020 Dec;41(12):1100-1115
pubmed: 33132005
World J Gastroenterol. 2004 May 1;10(9):1268-75
pubmed: 15112340
Nutrients. 2021 Oct 12;13(10):
pubmed: 34684572
Hum Genomics. 2023 Mar 7;17(1):19
pubmed: 36882862
CPT Pharmacometrics Syst Pharmacol. 2017 Jan;6(1):40-48
pubmed: 28019090
Front Immunol. 2021 Apr 13;12:653605
pubmed: 33927722
PLoS One. 2014 Nov 24;9(11):e111911
pubmed: 25419901
J Steroid Biochem Mol Biol. 2015 Jul;151:25-37
pubmed: 25448732
J Cell Physiol. 2006 Sep;208(3):566-74
pubmed: 16741990
Mol Cell Biochem. 2021 Jun;476(6):2421-2427
pubmed: 33604809
Mol Cell Endocrinol. 2021 Jun 15;530:111238
pubmed: 33716049
Front Immunol. 2021 Apr 01;12:622176
pubmed: 33868239
Antioxid Redox Signal. 2014 Mar 1;20(7):1126-67
pubmed: 23991888
Int J Mol Sci. 2018 Jun 05;19(6):
pubmed: 29874855
J Steroid Biochem Mol Biol. 2004 Oct;92(3):131-41
pubmed: 15555907
Biochem Soc Trans. 2015 Jun;43(3):349-58
pubmed: 26009175
Oxid Med Cell Longev. 2019 Nov 16;2019:3018584
pubmed: 31827671
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
BMC Med. 2020 Jul 15;18(1):216
pubmed: 32664879
PLoS Pathog. 2020 Sep 18;16(9):e1008874
pubmed: 32946517
Chem Biol. 2014 Mar 20;21(3):319-29
pubmed: 24529992
Crit Rev Clin Lab Sci. 2020 Sep;57(6):389-399
pubmed: 32503382
Antioxidants (Basel). 2020 Sep 29;9(10):
pubmed: 33003552
Pharmacogenet Genomics. 2009 Jun;19(6):477-88
pubmed: 19440163
EBioMedicine. 2021 Oct;72:103629
pubmed: 34655949
Exp Dermatol. 2020 Sep;29(9):885-890
pubmed: 32779213

Auteurs

Jessica Cusato (J)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Alessandra Manca (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Alice Palermiti (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Jacopo Mula (J)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Martina Costanzo (M)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Miriam Antonucci (M)

ASL Città di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Francesco Chiara (F)

Laboratory of Clinical Pharmacology S.Luigi A.O.U., Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole, Orbassano, 10043 Turin, Italy.

Elisa Delia De Vivo (ED)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Domenico Maiese (D)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Micol Ferrara (M)

ASL Città di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Stefano Bonora (S)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Giovanni Di Perri (G)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Antonio D'Avolio (A)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.

Andrea Calcagno (A)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.

Classifications MeSH